A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia

PLoS One. 2015 Oct 29;10(10):e0141455. doi: 10.1371/journal.pone.0141455. eCollection 2015.

Abstract

Background: We assessed the integration of early infant HIV diagnosis with the expanded programme for immunization in a rural Zambian setting with the aim of determining whether infant and postpartum maternal HIV testing rates would increase without harming immunization uptake.

Methods: In an unblinded, location stratified, cluster randomised controlled trial, 60 facilities in Zambia's Southern Province were equally allocated to a control group, Simple Intervention group that received a sensitization meeting and the resupply of HIV testing commodities in the event of a stock-out, and a Comprehensive Intervention group that received the Simple Intervention as well as on-site operational support to facilitate the integration of HIV testing services with EPI.

Findings: The average change in number of first dose diphtheria, pertussis, and tetanus vaccine (DPT1) provided per month, per facility was approximately 0.86 doses higher [90% confidence interval (CI) -1.40, 3.12] in Comprehensive Intervention facilities compared to the combined average change in the Simple Intervention and control facilities. The interventions resulted in a 16.6% [90% CI: -7%, 46%, P-value = 0.26] and 10% [90% CI: -10%, 36%, P-value = 0.43] greater change in average monthly infant DBS testing compared to control for the Simple and Comprehensive facilities respectively. We also found 15.76 (90% CI: 7.12, 24.41, P-value < 0.01) and 10.93 (90% CI: 1.52, 20.33, P-value = 0.06) additional total maternal re-tests over baseline for the Simple and Comprehensive Facilities respectively.

Conclusions: This study provides strong evidence to support Zambia's policy of integration of HIV testing and EPI services. Actions in line with the interventions, including HIV testing material supply reinforcement, can increase HIV testing rates without harming immunization uptake. In response, Zambia's Ministry of Health issued a memo to remind health facilities to provide HIV testing at under-five clinics and to include under-five HIV testing as part of district performance assessments.

Trial registration: ClinicalTrials.gov

Registration number: NCT02479659.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Delivery of Health Care, Integrated / methods*
  • Diphtheria-Tetanus-Pertussis Vaccine / therapeutic use*
  • Early Diagnosis
  • Female
  • HIV Seropositivity / diagnosis*
  • HIV Seropositivity / epidemiology
  • Health Facilities / statistics & numerical data*
  • Humans
  • Infant
  • Male
  • Rural Population
  • Vaccination / methods*
  • Vaccination / statistics & numerical data
  • Zambia

Substances

  • Diphtheria-Tetanus-Pertussis Vaccine

Associated data

  • ClinicalTrials.gov/NCT02479659

Grants and funding

This work was supported by a grant from the United Kingdom’s Department for International Development to the Clinton Health Access Initiative, Accountable Grant for Demand-Driven Impact Evaluations for Decisions, component code 203504-101, https://www.gov.uk/government/organisations/department-for-international-development/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.